BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38614940)

  • 1. Efficacy and safety of 0.5% colchicine cream versus 5% 5-fluorouracil cream in the treatment of cutaneous field cancerization: a randomized clinical trial.
    Teixeira AS; Martins IMC; Miola AC; Miot HA
    An Bras Dermatol; 2024 Apr; ():. PubMed ID: 38614940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
    Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
    Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol.
    Miola AC; Ferreira ER; Abbade LPF; Schmitt JV; Miot HA
    BMC Cancer; 2018 Mar; 18(1):340. PubMed ID: 29587662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.
    Alvares BA; Miola AC; Schimitt JV; Miot HA; Abbade LPF
    An Bras Dermatol; 2022; 97(2):157-165. PubMed ID: 35039206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
    Mohney L; Singh R; Grada A; Feldman S
    J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tretinoin (0.05% cream vs. 5% peel) for photoaging and field cancerization of the forearms: randomized, evaluator-blinded, clinical trial.
    Sumita JM; Miot HA; Soares JLM; Raminelli ACP; Pereira SM; Ogawa MM; Picosse FR; Guadanhim LRS; Enokihara MMSS; Leonardi GR; Bagatin E
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1819-1826. PubMed ID: 29704456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
    Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study.
    Guimarães CO; Miot HA; Bagatin E
    Dermatol Surg; 2014 Jun; 40(6):610-7. PubMed ID: 24852464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
    Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
    Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peeling with 70% glicolic acid followed by 5% 5-fluorouracil as well as 5% 5-fluorouracil cream are effective methods for the treatment of actinic keratoses on upper limbs: A randomized clinical trial.
    Heuser CL; Heuser GG; Casagrande J; de Fátima Pavan Zanella J; Winkelmann ER
    Dermatol Ther; 2020 May; 33(3):e13459. PubMed ID: 32323462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.
    Ingham AI; Weightman W
    Australas J Dermatol; 2014 Aug; 55(3):204-8. PubMed ID: 24627952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis.
    Hoover WD; Jorizzo JL; Clark AR; Feldman SR; Holbrook J; Huang KE
    Cutis; 2014 Nov; 94(5):255-9. PubMed ID: 25474455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.
    Loven K; Stein L; Furst K; Levy S
    Clin Ther; 2002 Jun; 24(6):990-1000. PubMed ID: 12117087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
    Tanghetti E; Werschler P
    J Drugs Dermatol; 2007 Feb; 6(2):144-7. PubMed ID: 17373172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
    Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
    Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
    Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight Photodynamic Therapy Versus 5-Fluorouracil for the Treatment of Actinic Keratosis: A Case Series.
    Galimberti GN
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):137-141. PubMed ID: 29322431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacy of 5-fluorouracil compared with other treatments among patients with actinic keratosis: A network meta-analysis.
    Wu Y; Tang N; Cai L; Li Q
    Dermatol Ther; 2019 May; 32(3):e12822. PubMed ID: 30638294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.